Interaction of Transfusion and Iron Chelation in Thalassemias
- PMID: 29458730
- DOI: 10.1016/j.hoc.2017.11.010
Interaction of Transfusion and Iron Chelation in Thalassemias
Abstract
The relationship between blood transfusion intensity, chelatable iron pools, and extrahepatic iron distribution is described in thalassemia. Risk factors for cardiosiderosis are discussed with particular reference to the balance of transfusional iron loading rate and transferrin-iron utilization rate as marked by plasma levels of soluble transferrin receptors. Low transfusion regimens increase residual erythropoiesis allowing for apotransferrin-dependent clearance of non-transferrin-bound iron species otherwise destined for myocardium. The impact of transfusion rates on chelation dosing required for iron balance is also shown.
Keywords: Cardiosiderosis; Chelators; Erythropoiesis; Hepcidin; Iron; Iron overload; Soluble transferrin receptor; Transfusion.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin.Haematologica. 2017 Oct;102(10):1640-1649. doi: 10.3324/haematol.2017.170605. Epub 2017 Jun 22. Haematologica. 2017. PMID: 28642302 Free PMC article.
-
Iron Chelation Therapy as a Modality of Management.Hematol Oncol Clin North Am. 2018 Apr;32(2):261-275. doi: 10.1016/j.hoc.2017.12.002. Epub 2018 Jan 17. Hematol Oncol Clin North Am. 2018. PMID: 29458731 Review.
-
Timed non-transferrin bound iron determinations probe the origin of chelatable iron pools during deferiprone regimens and predict chelation response.Haematologica. 2012 Jun;97(6):835-41. doi: 10.3324/haematol.2011.056317. Epub 2011 Dec 16. Haematologica. 2012. PMID: 22180427 Free PMC article. Clinical Trial.
-
Iron overload in thalassemia: different organs at different rates.Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):265-271. doi: 10.1182/asheducation-2017.1.265. Hematology Am Soc Hematol Educ Program. 2017. PMID: 29222265 Free PMC article. Review.
-
Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.Br J Haematol. 2017 Jan;176(2):288-299. doi: 10.1111/bjh.14373. Epub 2016 Dec 5. Br J Haematol. 2017. PMID: 27917462 Free PMC article. Clinical Trial.
Cited by
-
Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias.Br J Haematol. 2021 May;193(3):637-658. doi: 10.1111/bjh.17361. Epub 2021 Mar 15. Br J Haematol. 2021. PMID: 33723861 Free PMC article.
-
Excessive Reactive Iron Impairs Hematopoiesis by Affecting Both Immature Hematopoietic Cells and Stromal Cells.Cells. 2019 Mar 8;8(3):226. doi: 10.3390/cells8030226. Cells. 2019. PMID: 30857202 Free PMC article.
-
Use of rapid cardiac magnetic resonance imaging to guide chelation therapy in patients with transfusion-dependent thalassaemia in India: UMIMI study.Eur Heart J Qual Care Clin Outcomes. 2022 May 5;8(3):289-297. doi: 10.1093/ehjqcco/qcab089. Eur Heart J Qual Care Clin Outcomes. 2022. PMID: 34849707 Free PMC article.
-
Evaluation of thyroid hormones and ferritin level in patients with β-thalassemia.Med Pharm Rep. 2022 Apr;95(2):152-157. doi: 10.15386/mpr-2053. Epub 2022 Apr 28. Med Pharm Rep. 2022. PMID: 35721036 Free PMC article.
-
Synergistic silencing of α-globin and induction of γ-globin by histone deacetylase inhibitor, vorinostat as a potential therapy for β-thalassaemia.Sci Rep. 2019 Aug 12;9(1):11649. doi: 10.1038/s41598-019-48204-2. Sci Rep. 2019. PMID: 31406232 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical